Correction to: European Journal of Human Genetics (2024) 32:479–488 https://doi.org/10.1038/s41431-023-01507-5, published online 05 March 2024
The reference 55 had to be corrected.
The incorrect information was:
“ 55. Loong L, Cubuk C, Choi S, Allen S, Torr B, Garrett A, et al. Quantifying prediction of pathogenicity for within-codon concordance (PM5) using 7541 functional classifications of BRCA1 and MSH2 missense variants. Genet Med. 2022;24:552–63.”
The correct information is:
“55. Loong L, Garrett A, Allen S, Choi S, Durkie M, Callaway A, et al. Reclassification of clinically-detected sequence variants: Framework for genetic clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group UK). Genet Med. 2022;24:1867-77.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
McDevitt, T., Durkie, M., Arnold, N. et al. Correction: EMQN best practice guidelines for genetic testing in hereditary breast and ovarian cancer. Eur J Hum Genet (2024). https://doi.org/10.1038/s41431-024-01670-3
Published:
DOI: https://doi.org/10.1038/s41431-024-01670-3
